A multicentre, randomised, double-blind, parallel-group, placebo-controlled trial of apatinib in local progressive or metastatic radioactive iodine-refractory differentiated thyroid cancer

被引：0
|
作者：
Lin, Y. [1 ]
Qin, S. [2 ]
机构：
[1] Beijing Union Med Coll Hosp, Dept Nucl Med, Beijing, Peoples R China
[2] Peoples Liberat Army Canc Ctr, Nanjing, Jiangsu, Peoples R China
来源：
ANNALS OF ONCOLOGY | 2017年 / 28卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
471TiP
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Cabozantinib for radioiodine-refractory differentiated thyroid cancer (COSMIC-311): a randomised, double-blind, placebo-controlled, phase 3 trial
    Brose, Marcia S.
    Robinson, Bruce
    Sherman, Steven, I
    Krajewska, Jolanta
    Lin, Chia-Chi
    Vaisman, Fernanda
    Hoff, Ana
    Hitre, Erika
    Bowles, Daniel W.
    Hernando, Jorge
    Faoro, Leonardo
    Banerjee, Kamalika
    Oliver, Jennifer W.
    Keam, Bhumsuk
    Capdevila, Jaume
    LANCET ONCOLOGY, 2021, 22 (08): : 1126 - 1138
  • [22] Response of apatinib in progressive radioactive iodine-refractory differentiated thyroid cancer: One-year follow-up study
    Zhang, X.
    Lin, Y.
    ANNALS OF ONCOLOGY, 2017, 28 : 169 - 169
  • [23] The Cannabinoid Use in Progressive Inflammatory brain Disease (CUPID) trial: a randomised double-blind placebo-controlled parallel-group multicentre trial and economic evaluation of cannabinoids to slow progression in multiple sclerosis
    Ball, Susan
    Vickery, Jane
    Hobart, Jeremy
    Wright, Dave
    Green, Colin
    Shearer, James
    Nunn, Andrew
    Cano, Mayam Gomez
    MacManus, David
    Miller, David
    Mallik, Shahrukh
    Zajicek, John
    HEALTH TECHNOLOGY ASSESSMENT, 2015, 19 (12) : 1 - +
  • [24] A Multicentre, Randomised, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Sirukumab in the Treatment of Giant Cell Arteritis
    Schmidt, Wolfgang A.
    Dasgupta, Bhaskar
    Luqmani, Raashid
    Unizony, Sebastian H.
    Blockmans, Daniel
    Lai, Zhihong
    Kurrasch, Regina H.
    Lazic, Ivana
    Brown, Kurt
    Rao, Ravi
    RHEUMATOLOGY AND THERAPY, 2020, 7 (04) : 793 - 810
  • [25] A Multicentre, Randomised, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Sirukumab in the Treatment of Giant Cell Arteritis
    Wolfgang A. Schmidt
    Bhaskar Dasgupta
    Raashid Luqmani
    Sebastian H. Unizony
    Daniel Blockmans
    Zhihong Lai
    Regina H. Kurrasch
    Ivana Lazic
    Kurt Brown
    Ravi Rao
    Rheumatology and Therapy, 2020, 7 : 793 - 810
  • [26] Apatinib versus placebo in patients with locally advanced or metastatic, radioactive iodine-refractory, differentiated thyroid cancer: Post hoc analyses from the REALITY randomized clinical trial.
    Lin, Yan-Song
    Qin, Shukui
    Li, Zhiyong
    Hui Yang
    Wei Fu
    Li, Shaohua
    Chen, Wenxin
    Gao, Zairong
    Miao, Weibing
    Xu, Huiqin
    Qing Zhang
    Zhao, Xinming
    Bao, Jiandong
    Li, Linfa
    Yuan Ren
    Lin, Chenghe
    Jing, Shanghua
    Ma, Qingjie
    Jun Liang
    Guang Chen
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [27] Efficacy of andrographolide in not active progressive multiple sclerosis: a prospective exploratory double-blind, parallel-group, randomized, placebo-controlled trial
    Ethel Ciampi
    Reinaldo Uribe-San-Martin
    Claudia Cárcamo
    Juan Pablo Cruz
    Ana Reyes
    Diego Reyes
    Carmen Pinto
    Macarena Vásquez
    Rafael A. Burgos
    Juan Hancke
    BMC Neurology, 20
  • [28] Ginkgo biloba for mild to moderate dementia in a community setting: a pragmatic, randomised, parallel-group, double-blind, placebo-controlled trial
    McCarney, Rob
    Fisher, Peter
    Iliffe, Steve
    van Haselen, Robbert
    Griffin, Mark
    van der Meulen, Jan
    Warner, James
    INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY, 2008, 23 (12) : 1222 - 1230
  • [29] Donafenib in Progressive Locally Advanced or Metastatic Radioactive Iodine-Refractory Differentiated Thyroid Cancer: Results of a Randomized, Multicenter Phase II Trial
    Lin, Yan-Song
    Yang, Hui
    Ding, Yong
    Cheng, Yi-Zhuang
    Shi, Feng
    Tan, Jian
    Deng, Zhi-Yong
    Chen, Zhen-Dong
    Wang, Rong-Fu
    Ji, Qing-Hai
    Huang, Rui
    Li, Lin-Fa
    THYROID, 2021, 31 (04) : 607 - 615
  • [30] Efficacy of andrographolide in not active progressive multiple sclerosis: a prospective exploratory double-blind, parallel-group, randomized, placebo-controlled trial
    Ciampi, Ethel
    Uribe-San-Martin, Reinaldo
    Carcamo, Claudia
    Cruz, Juan Pablo
    Reyes, Ana
    Reyes, Diego
    Pinto, Carmen
    Vasquez, Macarena
    Burgos, Rafael A.
    Hancke, Juan
    BMC NEUROLOGY, 2020, 20 (01)
12345